Learning Center
Plans & pricing Sign in
Sign Out

2012 || Pharmaceuticals and Healthcare || Amnesia – Pipeline Review, H1 2012 ||


									             Amnesia – Pipeline Review, H1 2012 announces, The Latest market research report is available in
its vast collection:

RSS link of Global Markets Direct


Global Markets Direct’s, Amnesia - Pipeline Review, H1 2012, provides an overview
of the Amnesia therapeutic pipeline. This report provides information on the
therapeutic development for Amnesia, complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Amnesia. Amnesia - Pipeline Review,
H1 2012 is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Amnesia.
- A review of the Amnesia products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
- Coverage of the Amnesia pipeline on the basis of route of administration and
molecule type.
             Amnesia – Pipeline Review, H1 2012

Table of contents:

List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Amnesia Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Amnesia 6
Amnesia Therapeutics under Investigation by Universities/Institutes 8
Mid Clinical Stage Products 9
Comparative Analysis 9
Amnesia Therapeutics – Products under Investigation by Universities/Institutes 10
Amnesia – Therapeutics Assessment 11
Assessment by Monotherapy Products 11
Assessment by Route of Administration 12
Assessment by Molecule Type 14
Drug Profiles 16
Rosuvastatin - Drug Profile 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Midazolam Hydrochloride - Drug Profile 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Midazolam - Drug Profile 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Amnesia Therapeutics - Dormant Products 19
Appendix 20

List of Figures
            Amnesia – Pipeline Review, H1 2012

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H1 2012 Review, H1

Gastritis – Pipeline Review, H1 2012

Amnesia – Pipeline Review, H1 2012

Primary Biliary Cirrhosis – Pipeline Review, H1 2012

Congenital Heart Disease – Pipeline Review, H1 2012

Emphysema – Pipeline Review, H1 2012

Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2012

Pheochromocytoma – Pipeline Review, H1 2012

Neuralgia – Pipeline Review, H1 2012

Thromboembolism – Pipeline Review, H1 2012

Obsessive-Compulsive Disorder – Pipeline Review, H1 2012

Bone Cancer – Pipeline Review, H1 2012

Status Epilepticus – Pipeline Review, H1 2012
            Amnesia – Pipeline Review, H1 2012

Thrombocythaemia Myelofibrosis – Pipeline Review, H1 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare and

For More details Plz do contact :

Aarkstore Enterprise




To top